in conclusion , patients with pulmonary metastases seem to be the best responding group for interferon treatment in renal cell carcinoma and further trials , especially combined regimens with chemotherapy and/or other kinds of interferon should be tested .
C0007134
renal cell carcinoma
C0021747
interferon